Botulax 200

Botulax 200IU has Excellent Effect – Result appreciable improvement

Also, Simple Procedure – Just by few tiny injections

And, Short Treatment – 10 minutes, as short as a tea break

Also, No Down Time – Resume normal work right away

And, Fast Onset- Take only 2 to 3 days to see noticeable effect

Also, Outstanding Efficacy – Over 98% users satisfied with the Botulax® treatments

And, Proven efficacy & Safety – The efficacy and safety of Botulium Toxin Type A are proved and verified to be comparable to OnabotulinumtoxinA’s in clinical studies.

Also, Botulium Toxin Type A is for sale in over 25 countries.

Furthermore, Guaranteed Safety – Approved by Health Authorities with over 10 years’ clinical practices.

COMPOSITION

Botulium Toxin type A comes in dosage units of 50, 100 and 200.  Each vial contains the active ingredient, Clostridium botulinum toxin type A 50 units (U), Stabilizer: Human serum albumin 0.25mg and Sodium chloride (EP) 0.45mg.

Applications/Indications

Not just as a cosmetic Botox, Botulium Toxin Type A  is also therapeutic applications,

Botulium Toxin Type A is use to treat benign essential blepharspasm in patients 18 years of age and above.

For the treatment of equinus foot deformity due to spasticity in pediatric cerebral palsy for patients 2 years of age and above.

And as many know Botox,, for temporary improvement of serious glabellar wrinkles ranging from moderate to severe Also, associated with corrugators muscle and/or procerus muscle activities in adults over the age of 18 and below the age of 65.

The preservation is in a freezer or refrigerator and with a retain a shelf life of 24 months.

Dosages of Botulax 200IU

For blepharospasm the initial recommended dose is 1.25 – 2.5 U (0.05 mL to 0.1 mL volume at each site) injected into the medial and Also, lateral pre-tarsal orbicularis oculi of the upper lid and into the lateral pre-tarsal orbicularis oculi of the lower lid.

For pediatric cerebral palsy, administer a total dose of 4U/kg bodyweight  for the gastrocnemius muscle in patients with hemiplegia.

The maximum dose administered must not exceed 200U/patient at a time.

For Glabellar wrinkles reconstituted sterile saline, use 20U and Also, there are additional application instructions for best practice, actual amounts vary on the presentation of the client.

Effects of Botulax 200IU

In Blepharospasm, the effects should appear within three days and peak after three weeks.

Also, For pediatric cerebral palsy applications, the expectation is improvement within four weeks of the injection

The effects vary for glabellar wrinkles due to the usually individualized dosages.

Precautions

There is the possibility of reactions at the site of an injection,

including

asthenia,

generalized muscle weakness,

diplopia,

ptosis,

dysphagia,

dysphonia,

dysarthria,

urinary incontinence and

breathing difficulties.

Serious hypersensitivity is rare.  There is a caution for people with pre-existing neuromuscular disorders, and for those with corneal exposure and ulceration in blepharospasm.

Do not administer Botulium Toxin Type A at all if a patient has a known allergy to any of the ingredients, Also, if the patients have neuromuscular junctional disorders or known to have adverse reactions. Do not administer while taking muscle relaxants and some antibiotics.

In the case of overdose

In the case of an overdose we advise that effects may not be immediate.

It is further advised that the patient be monitored for muscle weakness and/or paralysis for a period of weeks after the occurrence.

There is an anti-toxin available but the caution with the anti-toxin is that it will not reduce any already apparent effects.

Facility: GMP approved by KFDA

Specifications 50iu/100iu/200iu

Brand BOTULAX

Place of Origin South Korea

Shelf Life 3 years in cold place